The prevalence of LOX1+PMNs in the peripheral blood and tissue of GBM patients, but not LOX1-PMNs, was shown to be inversely associated with the amount of effector immune cells in GBM patients, and was linked to early recurrence and disease progression. Here, OLR1 is linked to glioblastoma.